Sort
35,931 grants matching “parkinsons”
MULTIMODAL MRI TO PREDICT DBS MOTOR AND COGNITIVE OUTCOMES IN PARKINSONâS DISEASE
$646,040Melanie A Morrison · University Of California, San Francisco · R01 · FY2024 · NS
Repurposing novel selective drugs for treatment and decolonization of vancomycin resistant enterococci
$645,971Mohamed Seleem · Virginia Polytechnic Inst And St Univ · R01 · FY2021 · AI
Mechanisms Underlying TAAR1-induced Wakefulness and REM Sleep Suppression
$645,843Thomas S Kilduff · Sri International · R01 · FY2021 · NS
Studies on CDNF: a new class of neurotrophic proteins
$645,828Barry J Hoffer · National Institute On Drug Abuse · Z01 · FY2008 · DA
Systems-to-structure approaches for defining mitochondrial protein function
$645,775David J Pagliarini · Washington University · R35 · FY2022 · GM
Systems-to-structure approaches for defining mitochondrial protein function
$645,775David J Pagliarini · Washington University · R35 · FY2021 · GM
Systems-to-structure approaches for defining mitochondrial protein function
$645,775David J Pagliarini · Washington University · R35 · FY2023 · GM
Towards Therapeutics for Neurodegenerative Diseases
$645,645Stanley B Prusiner · University Of California, San Francisco · R37 · FY2017 · AG
Positive Allosteric Modulators as PET Imaging Ligans for mGluR4
$645,610Anna-Liisa Brownell · Massachusetts General Hospital · R01 · FY2017 · NS
Structural Basis of Signal Instigation Through Family C GPCRs
$645,521Georgios Skiniotis · Stanford University · R01 · FY2021 · NS
Diagnostic Innovations in Glaucoma Study: Visual Function
$645,518Felipe Medeiros · University Of California, San Diego · R01 · FY2010 · EY
Systems-to-structure approaches for defining mitochondrial protein function
$645,402David J Pagliarini · Washington University · R35 · FY2020 · GM
Identification of Critical Signaling Pathways Modulating Mast Cell Activation
$645,329Dean D Metcalfe · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Diagnostic and prognostic biomarkers for Parkinsons disease
$645,302Dwight C. German · Ut Southwestern Medical Center · U01 · FY2012 · NS
The role of ATP13A2/PARK9 in secretion of exosomes and alpha synuclein
$645,210Dimitri Krainc · Northwestern University At Chicago · R37 · FY2020 · NS
Parkinson's Disease Clinical Trial: Statistical Center
$645,146Barbara C Tilley · Medical University Of South Carolina · U01 · FY2007 · NS
Neurophysiological mechanisms underlying parkinsonian motor signs
$645,081Jerrold L Vitek · University Of Minnesota · R01 · FY2018 · NS
Biomarker Discovery and Validation in Parkinson's Disease
$644,960Ted M. Dawson · Johns Hopkins University · U01 · FY2018 · NS
Links Between Production and Perception in Speech
$644,953Doug H Whalen · Haskins Laboratories, Inc. · R01 · FY2009 · DC
An Interneuron-based Cell Therapy for Epilepsy
$644,947Scott Charles Baraban · University Of California, San Francisco · R37 · FY2019 · NS
Channel structure-based tools for precise interrogation of circuitry and behavior
$644,930Karl Alexander Deisseroth · Stanford University · R37 · FY2015 · MH
Channel structure-based tools for precise interrogation of circuitry and behavior
$644,930Karl Alexander Deisseroth · Stanford University · R37 · FY2014 · MH
Human iPSC-based personalized cell therapy of PD
$644,754Kwang-Soo Kim · Mclean Hospital · R01 · FY2018 · NS
Quality of Life for SCI Clinical Trials: Development of the SCI-QOL
$644,695David Scott Tulsky · Kessler Foundation, Inc. · R01 · FY2007 · HD
Fully Realizing Pangenomics Alignment
$644,578Christina Boucher · University Of Florida · R56 · FY2024 · HG